Key result
Brain-heart axis biomarkers HRV and QTc objectively quantify autonomic dysregulation in chronic orofacial pain.
Why the study?
Chronic orofacial pain research frequently suffers from the conflation of constructs, with psychosocial predictors and outcome measures often conceptually inseparable.
Integrating objective brain-heart axis biomarkers like HRV and QTc into chronic orofacial pain research could provide a mechanistic understanding of autonomic dysregulation.
Supports HRV and QTc use in chronic orofacial pain; extends brain-heart axis research but requires further validation.
The biopsychosocial model is the prevailing framework for chronic orofacial pain (COP). While COP is a heterogeneous clinical entity involving nociceptive and neuropathic components, it is increasingly defined by its nociplastic features—a systemic, non-nociceptive state in which psychological factors significantly influence symptoms. Current research frequently suffers from the conflation of constructs. Psychosocial predictors (e.g., self-efficacy) and outcome measures (e.g., pain interference) are often conceptually inseparable. To advance beyond this, we advocate for the integration of the brain-heart axis (BHA). The BHA provides objective, quantifiable markers of autonomic nervous system (ANS) dysregulation, the physical manifestation of chronic stress rooted in large-scale brain network imbalance. The present study proposes a theoretical framework in which psychological distress is reflected in corrected QT interval (QTc) changes, while low self-efficacy is mirrored by reduced heart rate variability (HRV). This integration is supported by the neurochemical roles of N-methyl-D-aspartate (NMDA) receptors in central sensitization and dopamine D2 receptor dysfunction in the basal ganglia. The present paper delineates a framework for research and clinical implementation within advanced dental training.
No takes yet. Share an insight, caveat, or question.
Takahiko Nagamine (2026) conducted a review in Chronic orofacial pain (COP). Brain-heart axis (BHA) biomarkers (HRV and QTc) was evaluated. Integrating brain-heart axis biomarkers like heart rate variability and corrected QT interval provides objective, quantifiable measures of autonomic dysregulation in chronic orofacial pain.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: